Skip to content
★ Sign in to follow
VK
Total declarations
5
Company
1
▲ Purchases (4 ops.)
€5,777
▼ Sales (0 ops.)
—

Latest filing published 20 Aug 2012 for Ernexa Therapeutics Inc., €748.

Insider track record

Disclosed buys
4
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
4
Positive at T+90
25%
Median T+90
-3.8%

Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 20 Aug 2012 · 5194 days ago · €748
    +90.0%
    Entry US$150,000.00 · Close at T+365 US$285,000.00
  • Filed 22 May 2012 · 5284 days ago · €551
    +105.0%
    Entry US$150,000.00 · Close at T+365 US$307,500.00
  • Filed 22 Dec 2011 · 5436 days ago · €1,351
    -11.5%
    Entry US$195,000.00 · Close at T+365 US$172,500.00
  • Filed 15 Sept 2011 · 5534 days ago · €3,127
    -53.5%
    Entry US$322,500.00 · Close at T+365 US$150,000.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Vladimir Khuchua: trading record in brief

This profile gathers the share dealings of Vladimir Khuchua in Ernexa Therapeutics Inc. Over a trading history stretching from 13 September 2011 to 16 August 2012, the count stands at 5 filings.

On the market, this insider has only ever bought: 4 purchases, €5,777 in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 share grant. So far in 2012, the count stands at 2 purchases and no sales.

The median purchase comes to €1,049. Ninety days after publication, 4 purchases show a median change of -3.8%, with the price up in 25% of them. They describe history only and say nothing certain about the share price ahead.

The latest filing, published on 20 August 2012, reports an open-market purchase of €748 in Ernexa Therapeutics Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Vladimir Khuchua

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total

5 of 5 declarations